← Browse by Condition
Medical Condition

acute coronary syndrome

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 4, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for acute coronary syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — acute coronary syndrome Clinical Trials

How many clinical trials are currently recruiting for acute coronary syndrome?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for acute coronary syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for acute coronary syndrome?
acute coronary syndrome research spans Phase 2 (2 trials), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a acute coronary syndrome clinical trial?
Eligibility criteria for acute coronary syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Phase 3
1
Phase 4
2
Top Sponsors
China National Center for Cardiovascular Diseases 1 trial
University of Texas Southwestern Medical Center 1 trial
IRCCS San Raffaele 1 trial
Fu Wai Hospital, Beijing, China 1 trial
St. Antonius Hospital 1 trial

Recruiting Clinical Trials

NCT05638867 Phase 4
Recruiting
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
Enrollment
3,944 pts
Location
China
Sponsor
China National Center for Card...
View Trial →
NCT07032389 Phase 2
Recruiting
A Polypill for Acute Coronary Syndrome
Enrollment
1,000 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT06441942
Recruiting
Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome
Enrollment
100 pts
Location
Italy
Sponsor
IRCCS San Raffaele
View Trial →
NCT04240834 Phase 4
Recruiting
Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
Enrollment
1,220 pts
Location
China
Sponsor
Fu Wai Hospital, Beijing, Chin...
View Trial →
NCT05926271 Phase 2
Recruiting
POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
Enrollment
200 pts
Location
Netherlands
Sponsor
St. Antonius Hospital
View Trial →
NCT04087200
Recruiting
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
Enrollment
2,500 pts
Location
Italy
Sponsor
Centro Cardiopatici Toscani
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Enrollment
2,000 pts
Location
United States, Canad...
Sponsor
DalCor Pharmaceuticals
View Trial →

Related Conditions

coronary artery disease (1) percutaneous coronary intervention (1) gender (1) genetic predisposition (1) interventional cardiology (1) cyp2c19 polymorphism (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology